Stock Price Movement and Market Context
On 30 March 2026, Mukka Proteins Ltd’s share price closed at Rs.18.74, representing a day-on-day decline of 4.06%. This new low is the lowest price the stock has traded at in the past year and also marks an all-time low. The stock has been on a three-day losing streak, cumulatively falling by 7.94% during this period. It has also underperformed the FMCG sector by 2.22% on the same day.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bearish trend. This technical positioning indicates that short-term and long-term momentum remain weak.
Meanwhile, the broader market has also experienced volatility. The Sensex opened sharply lower by 1,018 points and closed down by 203.28 points at 72,361.94, a decline of 1.66%. The benchmark index is trading close to its own 52-week low of 71,425.01, just 1.29% away, and remains below its 50-day moving average, which itself is positioned below the 200-day moving average, reinforcing a bearish market environment.
Long-Term Performance and Relative Comparison
Over the past year, Mukka Proteins Ltd has delivered a negative return of 42.17%, significantly underperforming the Sensex, which declined by 6.23% over the same period. The stock’s 52-week high was Rs.34.41, highlighting the extent of its decline from peak levels.
In addition to the one-year underperformance, the stock has lagged behind the BSE500 index over the last three years, one year, and three months, indicating persistent challenges in maintaining competitive returns within the broader market.
Fundamental Weaknesses and Financial Metrics
Mukka Proteins Ltd’s fundamental profile continues to weigh on its valuation and investor sentiment. The company has exhibited a negative compound annual growth rate (CAGR) of -4.98% in operating profits over the last five years, reflecting a contraction in core earnings capacity.
Its ability to service debt remains constrained, with a high Debt to EBITDA ratio of 5.26 times, signalling elevated leverage and potential financial risk. The average Return on Capital Employed (ROCE) stands at 9.16%, which is modest and suggests limited profitability relative to the capital invested.
Institutional investor participation has also declined, with a reduction of 1.5% in their stake over the previous quarter. Currently, institutional investors hold only 1.86% of the company’s equity, a relatively low level that may reflect cautious sentiment among sophisticated market participants.
Recent Quarterly Performance Highlights
Despite the broader challenges, the company reported positive quarterly results in December 2025, breaking a streak of seven consecutive quarters of negative performance. The quarterly profit after tax (PAT) rose to Rs.23.75 crores, representing a growth of 101.1% compared to the average of the previous four quarters.
Net sales for the quarter reached a record high of Rs.653.50 crores, while PBDIT (profit before depreciation, interest, and taxes) also hit a peak at Rs.45.44 crores. These figures indicate some operational improvement in the short term.
However, the company’s ROCE remains at 9.2%, and it is valued attractively with an enterprise value to capital employed ratio of 1.1, trading at a discount relative to its peers’ historical valuations. Despite this, the stock’s profits have declined by 25.1% over the past year, underscoring ongoing profitability pressures.
Technical Indicators and Market Sentiment
Technical analysis presents a mixed but predominantly bearish picture. The Moving Average Convergence Divergence (MACD) indicator is bearish on a weekly basis, while the Relative Strength Index (RSI) is neutral weekly but bullish monthly. Bollinger Bands signal bearish trends on both weekly and monthly charts.
Daily moving averages remain bearish, and the Dow Theory confirms a bearish stance on both weekly and monthly timeframes. The KST (Know Sure Thing) indicator shows mild bullishness weekly, but overall momentum remains subdued. On-balance volume (OBV) is mildly bearish weekly, with no clear trend monthly.
Summary of Key Concerns
The stock’s fall to a 52-week low reflects a combination of weak long-term financial performance, high leverage, and subdued institutional interest. Its sustained underperformance relative to the Sensex and sector peers highlights ongoing challenges in generating shareholder value. While recent quarterly results showed some improvement, the broader financial metrics and technical indicators suggest that the stock remains under pressure.
Market conditions, including the broader Sensex’s proximity to its own 52-week low and bearish technical positioning, have also contributed to the subdued performance of Mukka Proteins Ltd.
